Loading...
XJPX4578
Market cap28bUSD
Dec 20, Last price  
8,483.00JPY
1D
-0.60%
1Q
7.08%
Jan 2017
66.56%
IPO
324.36%
Name

Otsuka Holdings Co Ltd

Chart & Performance

D1W1MN
XJPX:4578 chart
P/E
37.29
P/S
2.25
EPS
227.48
Div Yield, %
1.23%
Shrs. gr., 5y
0.03%
Rev. gr., 5y
9.33%
Revenues
2.02t
+16.14%
955,947,000,0001,084,291,000,0001,090,212,000,0001,154,573,000,0001,218,055,000,0001,452,759,000,0001,599,424,000,0001,445,227,000,0001,195,547,000,0001,239,952,000,0001,291,981,000,0001,396,240,000,0001,422,826,000,0001,498,276,000,0001,737,998,000,0002,018,568,000,000
Net income
121.62b
-9.18%
47,083,000,00067,443,000,00081,001,000,00092,174,000,000122,429,000,000150,989,000,000151,237,000,00084,086,000,00092,563,000,000112,492,000,00082,492,000,000127,151,000,000148,137,000,000125,463,000,000133,906,000,000121,616,000,000
CFO
283.23b
+33.70%
58,470,000,000173,508,000,00086,393,000,000147,618,000,000119,340,000,000226,461,000,000118,046,637,155253,873,000,000142,004,000,000102,832,000,000135,821,000,000192,634,000,000232,839,000,000228,864,000,000211,848,000,000283,232,000,000
Dividend
Dec 27, 202460 JPY/sh
Earnings
Feb 12, 2025

Profile

Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a drinkable-liquid; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.
URL
https://www.otsuka.com/jp/
IPO date
Dec 15, 2010
Employees
33,482
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
2,018,568,000
16.14%
1,737,998,000
16.00%
1,498,276,000
5.30%
Cost of revenue
1,726,378,000
1,568,860,000
1,349,655,000
Unusual Expense (Income)
NOPBT
292,190,000
169,138,000
148,621,000
NOPBT Margin
14.48%
9.73%
9.92%
Operating Taxes
17,155,000
35,534,000
34,429,000
Tax Rate
5.87%
21.01%
23.17%
NOPAT
275,035,000
133,604,000
114,192,000
Net income
121,616,000
-9.18%
133,906,000
6.73%
125,463,000
-15.31%
Dividends
(55,653,000)
(55,561,000)
(55,984,000)
Dividend yield
1.94%
2.38%
2.48%
Proceeds from repurchase of equity
(1,000)
(1,000)
BB yield
0.00%
0.00%
Debt
Debt current
88,272,000
44,157,000
49,973,000
Long-term debt
201,477,000
223,950,000
239,302,000
Deferred revenue
44,869,000
50,736,000
57,771,000
Other long-term liabilities
59,740,000
70,826,000
60,005,000
Net debt
(700,041,000)
(622,691,000)
(523,155,000)
Cash flow
Cash from operating activities
283,232,000
211,848,000
228,864,000
CAPEX
(114,673,000)
(107,787,000)
(113,152,000)
Cash from investing activities
(190,538,000)
(81,575,000)
(95,288,000)
Cash from financing activities
(60,168,000)
(95,474,000)
(95,844,000)
FCF
150,796,000
102,834,000
118,484,000
Balance
Cash
513,341,000
489,115,000
430,758,000
Long term investments
476,449,000
401,683,000
381,672,000
Excess cash
888,861,600
803,898,100
737,516,200
Stockholders' equity
1,974,755,000
1,800,822,000
1,598,082,000
Invested Capital
1,866,251,400
1,746,031,900
1,627,411,800
ROIC
15.23%
7.92%
7.22%
ROCE
10.50%
6.56%
6.21%
EV
Common stock shares outstanding
542,668
542,556
542,377
Price
5,289.00
22.86%
4,305.00
3.26%
4,169.00
-5.64%
Market cap
2,870,171,052
22.88%
2,335,703,580
3.30%
2,261,169,713
-5.63%
EV
2,212,764,052
1,750,152,580
1,786,256,713
EBITDA
389,967,000
262,899,000
233,476,000
EV/EBITDA
5.67
6.66
7.65
Interest
6,523,000
6,063,000
4,840,000
Interest/NOPBT
2.23%
3.58%
3.26%